The Liddy Shriver Sarcoma Initiative helping those dealing with sarcoma.                      HOME
Liddy's Story
Sarcomas
Clinical Trials
ESUN
Funded Research
Sarcoma Calendar
Initiatives
Personal Journeys
Links
News
Donations
Volunteer
First Time Visitors
Searching Our Website
Guest Book

Refractory/Recurrent
Up
Exatecan
Gemcitabine+Docetaxel
Irinotecan+Temozolomide
Lung Matastases
Platinum Compounds
Poor Response
Stem Cell Rescue
Topotecan+Cyclophoshamide
Unknown Effect
 

Topotecan + Cyclophoshamide

 

Basic Information for Topotecan

  • Topotecan is also called topotecan hydrochloride, NSC-609699, and Hycamtin

  • It inhibits the action of topoisomerase I, an enzyme that produces reversible single-strand breaks in DNA during DNA replication.

  • Given via IV

  • Approved by FDA for ovarian and lung cancers

Basic Information for Cyclophoshamide

  • Cyclophoshamide is also called Cyclo, CPA, CPM, CTX, CYC, CYT, Cytoxan, Procyton, and Neosar

  • Given IV or orally

  • FDA-approved for many cancers; available for decades

Related Papers

  • 2000 abstract describing using cyclophosphamide and topotecan for resistant solid tumors; discusses the dosage and side effects.